Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

por Vallianou, Natalia G., Christodoulatos, Gerasimos Socrates, Kounatidis, Dimitris, Dalamaga, Maria
Publicado 2021

Mycobiome and Cancer: What Is the Evidence?

por Vallianou, Natalia, Kounatidis, Dimitris, Christodoulatos, Gerasimos Socrates, Panagopoulos, Fotis, Karampela, Irene, Dalamaga, Maria
Publicado 2021

Effects of T3 Administration on Ex Vivo Rat Hearts Subjected to Normothermic Perfusion: Therapeutic Implications in Donor Heart Preservation and Repair

por Mourouzis, Iordanis, Kounatidis, Dimitris, Brozou, Vassiliki, Anagnostopoulos, Dimitris, Katsaouni, Athanasia, Lourbopoulos, Athanasios, Pantos, Constantinos
Publicado 2023

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

por Vallianou, Natalia, Christodoulatos, Gerasimos Socrates, Karampela, Irene, Tsilingiris, Dimitrios, Magkos, Faidon, Stratigou, Theodora, Kounatidis, Dimitris, Dalamaga, Maria
Publicado 2021

The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices

por Vallianou, Natalia G., Skourtis, Alexandros, Kounatidis, Dimitris, Margellou, Evangelia, Panagopoulos, Fotis, Geladari, Eleni, Evangelopoulos, Angelos, Jahaj, Edison
Publicado 2023

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives

por Vallianou, Natalia G., Kounatidis, Dimitris, Tsilingiris, Dimitrios, Panagopoulos, Fotis, Christodoulatos, Gerasimos Socrates, Evangelopoulos, Angelos, Karampela, Irene, Dalamaga, Maria
Publicado 2023

SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?

por Kounatidis, Dimitris, Vallianou, Natalia, Evangelopoulos, Angelos, Vlahodimitris, Ioannis, Grivakou, Eugenia, Kotsi, Evangelia, Dimitriou, Krystalia, Skourtis, Alexandros, Mourouzis, Iordanis
Publicado 2023